Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (11219)	8/16/1999 4:44:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

2:15 not 2:30!!!!!! Conference Call Notice XOMA Ltd. (Nasdaq: XOMA) Jack Castello, Chairman, President and CEO, and members of XOMA management will make a statement regarding today's release of second quarter financial results and business update including the status of the Company's Phase III pivotal trial of NEUPREX® in severe pediatric meningococcemia TODAY: Monday, August 16,1999 at 5:15 p.m. Eastern (2:15 pm Pacific) To listen to this presentation from inside the United States, dial: (800) 230-1092 from outside the United States, dial: 612 332-1214 shortly before 5:15 pm Eastern (2:15 pm Pacific)